We evaluated a simplified method for preparation and analysis of plate
let cytochrome c oxidase activity in Alzheimer's disease (AD) and cont
rol patients. Mean cytochrome c oxidase activity in controls (n = 17)
was 0.233 sec(-1)/mg whereas mean cytochrome c oxidase activity in Alz
heimer patients (n = 19) was 0.193 sec(-1)/mg, p = 0.033. Complex III
(ubiquinol:cytochrome c oxidoreductase), complex II (succinic dehydrog
enase), and citrate synthase were all assayed as internal controls and
were not significantly different in controls and Alzheimer patients.
There is a relatively specific loss of platelet cytochrome c oxidase a
ctivity in Alzheimer disease patients.